Treace Medical Concepts, Inc. TMCI

TMCI Company Overview

Treace Medical Concepts, Inc. is a U.S.-based medical technology company focused on the surgical treatment of bunion and related midfoot deformities. The company operates within the orthopedic and podiatric medical device industry and develops procedure-specific solutions intended to improve outcomes for hallux valgus correction. Treace is best known for its proprietary Lapiplasty® 3D Bunion Correction™ system, which is designed to address the three-dimensional nature of bunion deformities through triplanar correction and stabilization of the affected joint. Revenue is primarily generated through the sale of surgical implants, disposable instruments, fixation systems, and procedural kits used by orthopedic surgeons and podiatrists.

The company serves hospitals, ambulatory surgery centers, and physician practices primarily in the United States, with growing international distribution activity. Treace positions itself as a specialized innovator focused on procedural standardization and surgeon education in bunion surgery, differentiating itself from broader orthopedic device manufacturers through a concentrated portfolio and clinically focused commercialization strategy. Founded in 2013 and headquartered in Ponte Vedra, Florida, the company expanded rapidly following commercialization of the Lapiplasty system and completed its initial public offering in 2021.